Analysts and fund managers have been advising investors to stay with largecaps.
Incidentally, most brokerages have turned overweight on the same set of stocks.
Largecap pharma stocks such as Sun, Aurobindo, Glenmark have climbed 10-16% in June.
Stay diversified with a reasonable amount of contrarian positioning.
Analysts say growth outlook for this sector continues to be robust.
This Mumbai finance pro gave up top job to turn stock investor, has a knack for picking multibaggers
Dave speaks about the market and investing with the conviction of a two-generation veteran.
Abhishek Basumallick says these confessions that market pundits are making is a good trend.
India’s HNI population grew at 9.5% to 2.19 lakh in 2016 against the global average of 7.5%.
As a whole, India Inc saw sales growth of more than 10 per cent YoY for Q4 of FY18.
Healthcare counters buzzed big time following a string of USFDA approvals for Indian drugmakers.
- No blogs yet have been written by the author, we’re sure the author will contribute one soon